Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. May 15, 2021; 13(5): 424-439
Published online May 15, 2021. doi: 10.4251/wjgo.v13.i5.424
Published online May 15, 2021. doi: 10.4251/wjgo.v13.i5.424
HR | 95%CI | P value | |
Age (yr) | 1.02 | 0.96-1.08 | 0.493 |
Preoperative MELD score | 1.37 | 1.16-1.62 | < 0.001c |
Preoperative AFP (ng/mL) | 1.001 | 1-1.002 | 0.08 |
BCLC stage | |||
0 | Reference | Reference | 0.757 |
A | 0.59 | 0.12-2.91 | |
B | 0.45 | 0.06-3.65 | |
PHLF grade | |||
Absent | Reference | Reference | < 0.001c |
A | 2.33 | 0.59-9.24 | |
B | 3.15 | 1.11-8.95 | |
C | 373.41 | 66.23-2105.43 | |
Postoperative MELD score > 10 | 1.03 | 0.39-2.67 | 0.958 |
Postoperative decompensation | 2.03 | 0.64-6.46 | 0.23 |
HCC recurrence | 11.67 | 4.19-32.52 | < 0.001c |
- Citation: Elshaarawy O, Aman A, Zakaria HM, Zakareya T, Gomaa A, Elshimi E, Abdelsameea E. Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis. World J Gastrointest Oncol 2021; 13(5): 424-439
- URL: https://www.wjgnet.com/1948-5204/full/v13/i5/424.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i5.424